Abstract
To evaluate the evidence for denosumab for the treatment of bone metastases secondary to solid tumours and, using a network meta-analysis, indirectly compare denosumab with bisphosphonates and best supportive care.
Original language | English |
---|---|
Pages (from-to) | 416-30 |
Number of pages | 15 |
Journal | European Journal of Cancer |
Volume | 49 |
Issue number | 2 |
DOIs | |
Publication status | Published - Jan 2013 |
Keywords
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Bone Neoplasms
- Humans
- Neoplasms
- Survival Analysis